Sabra Healthcare Company Insiders

SBRA Stock  USD 17.26  0.07  0.40%   
Sabra Healthcare's insiders are aggressively buying. The analysis of insiders' sentiment of trading Sabra Healthcare REIT stock suggests that vertually all insiders are extremely bullish at this time. Sabra Healthcare employs about 50 people. The company is managed by 11 executives with a total tenure of roughly 45 years, averaging almost 4.0 years of service per executive, having 4.55 employees per reported executive.
Richard Matros  Chairman
Chairman, CEO and Pres
Talya NevoHacohen  President
Executive Vice President Chief Investment Officer, Treasurer

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2025-02-24Catherine CusackAcquired 1500 @ 15.92View
2025-02-21Catherine CusackAcquired 1000 @ 16.43View
2024-05-22Catherine CusackAcquired 7000 @ 14.43View
Monitoring Sabra Healthcare's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Sabra Healthcare's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Sabra Healthcare's future performance. Based on our forecasts, it is anticipated that Sabra will maintain a workforce of about 50 employees by April 2025.
 
Credit Downgrade
 
Yuan Drop
 
Covid

Sabra Healthcare Management Team Effectiveness

The company has return on total asset (ROA) of 0.03 % which means that it generated a profit of $0.03 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0457 %, meaning that it created $0.0457 on every $100 dollars invested by stockholders. Sabra Healthcare's management efficiency ratios could be used to measure how well Sabra Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.05, whereas Return On Tangible Assets are forecasted to decline to 0.02. At present, Sabra Healthcare's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 6.2 M, whereas Total Assets are forecasted to decline to about 4.3 B.
As of March 24, 2025, Common Stock Shares Outstanding is expected to decline to about 139.7 M. The current year's Net Loss is expected to grow to about (66.4 M)

Sabra Healthcare Workforce Comparison

Sabra Healthcare REIT is rated fifth in number of employees category among its peers. The total workforce of Real Estate industry is at this time estimated at about 1,926. Sabra Healthcare holds roughly 50.0 in number of employees claiming about 2.6% of equities listed under Real Estate industry.

Sabra Healthcare Profit Margins

The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.37 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.37.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.90.6771
Significantly Up
Slightly volatile
Operating Profit Margin0.470.39
Fairly Up
Pretty Stable

Sabra Healthcare Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sabra Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sabra Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Sabra Healthcare insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
1.1667
7
6
 603,427 
 353,670 
2024-09-01
11.0
11
1
 25,051 
 1,350 
2024-06-01
19.0
19
1
 101,515 
 10,000 
2024-03-01
2.125
17
8
 367,978 
 182,242 
2023-03-01
2.5
15
6
 196,433 
 120,677 
2022-09-01
11.0
11
1
 16,063 
 2,600 
2022-03-01
3.25
13
4
 270,673 
 390,133 
2021-12-01
8.0
16
2
 199,934 
 111,325 
2021-03-01
1.8
27
15
 576,407 
 157,886 
2020-12-01
15.0
15
1
 156,794 
 0.00 
2020-06-01
19.0
19
1
 72,234 
 6,000 
2020-03-01
1.5294
26
17
 345,059 
 282,084 
2019-12-01
8.0
16
2
 116,304 
 114,000 
2019-09-01
6.5
13
2
 14,540 
 73,000 
2019-03-01
2.625
21
8
 239,324 
 98,141 
2018-12-01
2.6667
16
6
 141,515 
 14,751 
2018-03-01
1.8889
17
9
 36,947 
 24,436 
2017-12-01
3.2
16
5
 142,897 
 26,962 
2017-09-01
22.0
22
1
 1,598,480 
 75,717 
2017-06-01
13.0
13
1
 23,839 
 1,100 
2017-03-01
4.0
16
4
 259,967 
 144,450 
2016-12-01
3.25
13
4
 84,270 
 24,616 
2016-09-01
9.0
9
1
 5,045 
 1,600 
2016-06-01
13.0
13
1
 25,556 
 2,000 
2016-03-01
1.5
18
12
 150,716 
 90,133 
2015-12-01
1.4615
19
13
 112,068 
 33,462 
2015-09-01
9.0
9
1
 5,083 
 1,150 
2015-03-01
1.6923
22
13
 384,929 
 222,285 
2014-12-01
1.25
15
12
 127,843 
 186,207 
2014-03-01
1.2381
26
21
 636,410 
 358,884 
2013-12-01
1.1429
16
14
 80,773 
 57,590 
2013-06-01
7.0
14
2
 11,732 
 1,925 
2013-03-01
1.2941
22
17
 657,745 
 700,971 
2012-12-01
2.4286
17
7
 73,291 
 44,519 
2012-06-01
7.0
14
2
 57,723 
 83,280 
2012-03-01
3.0
18
6
 164,178 
 50,737 
2011-06-01
4.6667
14
3
 60,557 
 99,171 
2011-03-01
2.0
2
1
 1,488 
 23,287 

Sabra Healthcare Notable Stakeholders

A Sabra Healthcare stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sabra Healthcare often face trade-offs trying to please all of them. Sabra Healthcare's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sabra Healthcare's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Richard MatrosChairman, CEO and PresProfile
Talya NevoHacohenExecutive Vice President Chief Investment Officer, TreasurerProfile
Michael CPACFO VPProfile
Harold AndrewsCFO, Executive VP, Secretary and ControllerProfile
Jessica FloresChief VPProfile
Peter NylandExecutive ManagementProfile
Michael CostaCFO VPProfile
Eliza GozarSenior InvestmentsProfile
Kara PappandurosSenior ManagementProfile
Darrin SmithExecutive InvestmentsProfile
Lukas CFAExecutive FinanceProfile

About Sabra Healthcare Management Performance

The success or failure of an entity such as Sabra Healthcare REIT often depends on how effective the management is. Sabra Healthcare management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sabra management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sabra management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.02  0.02 
Return On Capital Employed 0.04  0.05 
Return On Assets 0.02  0.02 
Return On Equity 0.05  0.04 
Please note, the presentation of Sabra Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sabra Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sabra Healthcare's management manipulating its earnings.

Sabra Healthcare Workforce Analysis

Traditionally, organizations such as Sabra Healthcare use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sabra Healthcare within its industry.

Sabra Healthcare Manpower Efficiency

Return on Sabra Healthcare Manpower

Revenue Per Employee14.1M
Revenue Per Executive63.9M
Net Income Per Employee2.5M
Net Income Per Executive11.5M
Working Capital Per Employee7.1M
Working Capital Per Executive32.3M

Complementary Tools for Sabra Stock analysis

When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals